JG
IONS icon

Jain Global’s Ionis Pharmaceuticals IONS Stock Holding History

Jain Global’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
32,931
+6,646
+25% +$500K 0.01% 708
2026
Q1 		$1.97M Sell
26,285
-329,974
-93% -$26M 0.01% 688
2025
Q4 		$28.2M Buy
356,259
+130,520
+58% +$9.83M 0.14% 150
2025
Q3 		$14.8M Buy
225,739
+218,544
+3,037% +$10.7M 0.07% 180
2025
Q2 		$284K Sell
7,195
-1,400
-16% -$45.8K ﹤0.01% 904
2025
Q1 		$259K Buy
+8,595
New +$281K ﹤0.01% 731

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jain Global's IONS Position: Q2 2026 in Review

Jain Global increased its Ionis Pharmaceuticals (IONS) stake by 25% in Q2 2026, buying an estimated $500K and bringing the position to 32,931 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #708.

Jain Global first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. The position peaked at $28.2M in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Jain Global held 32,931 shares of Ionis Pharmaceuticals worth $2.61M as of Q2 2026.
  • Jain Global bought 6,646 Ionis Pharmaceuticals shares in Q2 2026, an estimated $500K.
  • Ionis Pharmaceuticals made up 0.01% of Jain Global's portfolio in Q2 2026, its #708 holding.
  • Jain Global first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Jain Global's Ionis Pharmaceuticals position peaked at $28.2M in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.